Pay in 4 interest-free payments of $5.60 Learn more
Ships within 48 hours · Estimated delivery Nov 3 - Nov 8
Introduction Glucagon-like peptide-1 receptor agonists (GLP-1 RA) are increasingly used for diabetes and weight loss management
Tirzepatide is a dual GIP/GLP-1 receptor agonist, which may lead to stronger appetite reduction and greater average weight loss for some patients
UAN: 0430-0000-19-106-H01-P Credits: 2.0 hours (0.20 ceu) Type of Activity: Knowledge TARGET AUDIENCE: This accredited activity is targeted to pharmacists
What insurance plans cover weight loss medication under Medicaid depends entirely on whether the state has elected to include anti-obesity medications in its preferred drug list
NICE guidance TA1026 supports a personalised approach to dose management rather than a fixed escalation schedule
US$ 21.00
US$ 22.61
US$ 28.43
US$ 20.82
US$ 22.42
US$ 29.09
